Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest Expense - DebtInterest Expense - DepositsInterest ExpensesInterest ExpensesInterest Income - Fed FundsInterest Income - NetInterest Income - TotalInterest Income - TotalInterest income - LoansInvestment Banking IncomeNet Income towards Common StockholdersNon Operating IncomeNon-Interest IncomeOperating ExpensesOther Non-Interest IncomeOther Operating ExpensesProfit After TaxProvisionsResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

MetroCity Bankshares (MCBS) Research & Development (2018 - 2025)

MetroCity Bankshares (MCBS) has disclosed Research & Development for 8 consecutive years, with $466000.0 as the latest value for Q4 2025.

  • Quarterly Research & Development rose 39.1% to $466000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, up 18.64% year-over-year, with the annual reading at $1.5 million for FY2025, 18.64% up from the prior year.
  • Research & Development for Q4 2025 was $466000.0 at MetroCity Bankshares, up from $394000.0 in the prior quarter.
  • The five-year high for Research & Development was $466000.0 in Q4 2025, with the low at $252000.0 in Q4 2021.
  • Average Research & Development over 5 years is $312550.0, with a median of $300500.0 recorded in 2023.
  • Peak annual rise in Research & Development hit 40.8% in 2021, while the deepest fall reached 19.49% in 2021.
  • Over 5 years, Research & Development stood at $252000.0 in 2021, then increased by 13.89% to $287000.0 in 2022, then rose by 4.88% to $301000.0 in 2023, then rose by 11.3% to $335000.0 in 2024, then surged by 39.1% to $466000.0 in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $466000.0, $394000.0, and $329000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.